Thiamine


Generic Medicine Info
Indications and Dosage
Oral
Thiamine deficiency
Adult: Up to 300 mg daily.

Oral
Treatment and prophylaxis of mild chronic thiamine deficiency
Adult: 10-25 mg daily in single or divided doses.

Parenteral
Wernicke-Korsakoff syndrome
Adult: Initially, 100 mg by slow IV Inj over 10 min, then 50-100 mg/day IM or IV until the patient can take oral thiamine.
Administration
Should be taken with food.
Incompatibility
Parenteral:
Alkaline or neutral solutions and with oxidizing and reducing agents.
Special Precautions
Parenteral admin. Increased daily requirements in pregnancy and lactation.
Adverse Reactions
IV: Warm sensation, tingling, pruritus, pain, urticaria, weakness, sweating, nausea, restlessness, tightness of the throat, angioedema, respiratory distress, cyanosis, pulmonary oedema, GI bleeding, transient vasodilation and hypotension, vascular collapse. IM: Tenderness and induration.
Potentially Fatal: Very rarely, fatal anaphylactic shock.
IM/IV/Parenteral/PO: A
Drug Interactions
May enhance the effect of neuromuscular blocking agents.
Lab Interference
False-positive results in the phosphotungstate method for uric acid determination and in the urine spot test with Ehrlich's reagent for urobilinogen. High doses of thiamine reportedly interfere with the Schack and Waxler spectrophotometric determination of theophylline serum concentrations.
Action
Description: Thiamine, a water soluble vitamin, combines with ATP to form thiamine pyrophosphate, an essential coenzyme in carbohydrate metabolism.
Pharmacokinetics:
Absorption: Well-absorbed from the GI tract after oral admin and rapidly and completely absorbed following IM administration.
Distribution: Widely distributed in most body tissues; enters breastmilk.
Excretion: Excess thiamine is excreted in the urine as metabolites and unchanged drug.
Storage
Store between 15-30°C.
Disclaimer: This information is independently developed by MIMS based on Thiamine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 MIMS. All rights reserved. Powered by MIMS.com
  • Licobevit-50
  • Vitamin B1 IPI
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in